Evidence Report: Risk of Cardiovascular Adaptations Contributing to Adverse Mission Performance and Health Outcomes
- Source:
- NASA Human Research Program — Human Health and Countermeasures Element · Lyndon B. Johnson Space Center
- Authors:
- Lee SMC, Saha J, Charvat J, Suresh R, Lytle JR, Blattnig S, Laurie SS, Macias BR ·
- Approved for public release: December 15, 2022
Official risk statement (verbatim)
“Given exposure to the spaceflight environment can contribute to cardiovascular deconditioning, dysfunction, and remodeling, there is a possibility that crews will experience impaired performance and adverse cardiovascular health outcomes that necessitate intervention during and after spaceflight and planetary operations.”
HRR risk page — Risk Statement
Key points (verbatim quotes)
- “Development of dysrhythmias and venous thromboembolism (VTE), which has been reported recently, are the primary concerns during a spaceflight mission.”— Evidence report — Executive Summary
- “…while there have been anecdotal reports and some documented cases of cardiac dysrhythmias during and after spaceflight, it is inconclusive whether spaceflight exposure causes or increases the frequency of these.”— Evidence report — Executive Summary
- “Orthostatic intolerance after short- and long-duration spaceflight in low Earth orbit (LEO) is well-documented and is considered the primary risk during re-exposure to acceleration, including re-entry and landing on Earth.”— Evidence report — Executive Summary
- “Cardiovascular disease (CVD) is considered the primary long-term health risk and concern for flight certification, especially for long-duration missions beyond LEO when exposure to space radiation will be greatest.”— Evidence report — Executive Summary
How ASTRA Health uses it
Scientific context for why ASTRA Health monitors heart rate and treats a sustained change as an event that needs attention. No heart-rate limit, alarm level or rule in the application is taken from this report.
No threshold derivedRelated official records
Limitations
- The report itself states that it is inconclusive whether spaceflight causes or increases cardiac dysrhythmias.
- It is a review of research evidence approved for public release in December 2022 — not an operational procedure, a medical standard or an alarm specification.
- ASTRA Health only simulates heart rate: dysrhythmias, venous thromboembolism and orthostatic intolerance cannot be detected from its signals.
Links and quotes verified against the official source on 2026-11-15.